I understand that the higher the share price the less the cost to CTIX to access the funds available from Aspire Captial.  I also realize the costs will be large if CTIX funds Ph2/3 trials for both Kevetrin and Prurisol.

But wouldn't success in the current PH1/2 trials for both Kevetrin and Prurisol, as I believe the current trials for both will show efficacy as well  as determine MTD, allow funds directed to CTIX from Cancer Institute or govt for such a wide-ranging cancer solution?

Is your belief in an uplisting based on your thinking that CTIX will not sell right after these initial trials prove successful?  Do you believe CTIX will be around for at least another year or 2 min to get further down the line before LE okays a buyout as I know he has said the value of the company rises dramatically the further we get in the trials process?

I believe LE wants to unload CTIX pretty quickly, no basis other than gut feeling (maybe just my wishful thinking), and I would like to hear more of the reasons others, such as I feel is your belief, that CTIX is going to be around for another couple of years.

TIA